Ginkgo Bioworks Holdings, Inc. (DNA) Social Stream



Ginkgo Bioworks Holdings, Inc. (DNA): $2.38

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add DNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Ginkgo Bioworks Holdings Inc (DNA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Ginkgo Bioworks Holdings Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 2 $14.5 $14 $14.25 $4.13 245.04%
2021-11-29 3 $16 $14 $14.833 $4.13 259.15%
2021-12-14 3 $14.5 $14 $14.166 $4.13 243%
2022-01-13 4 $14.5 $12 $13.625 $4.13 229.9%
2022-01-18 4 $14.5 $11.5 $13 $4.13 214.77%
2022-01-28 5 $14.5 $8 $12 $4.13 190.56%
2022-02-01 5 $14.5 $6 $11.6 $4.13 180.87%
2022-03-31 6 $14.5 $6 $11.666 $4.13 182.47%

The Trend in the Analyst Price Target


Over the past 107 days, DNA's average price target has gone down $2.5.

Over the past 164 days, DNA's average upside potential has been 93.81%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-29 3 16.0 14.0 14.833 12.04 23.2%
2022-01-13 4 14.5 12.0 13.625 6.14 121.91%
2022-01-18 4 14.5 11.5 13.000 5.30 145.28%
2022-01-18 5 14.5 11.5 13.000 5.30 145.28%
2022-03-04 6 14.5 6.0 11.666 3.43 240.12%

DNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 4 1 1 0 0 6

The Trend in the Broker Recommendations


Over the past 151 days, DNA's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Ginkgo Bioworks Holdings Inc's upside potential (average analyst target price relative to current price) is greater than 1074.18% of all US stocks.
  • In terms of how Ginkgo Bioworks Holdings Inc fares relative to stocks in the large market cap category, note that its average analyst price target is higher than 60.17% of that group.
  • To contextualize these metrics, consider that out of stocks in the large market cap category, Ginkgo Bioworks Holdings Inc's number of analysts covering the stock is higher than 66.06% of them.
  • DNA has a lower variance in analysts' estimates than -293.14% of stocks in the large market cap category.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Ginkgo Bioworks Holdings Inc are CRSP, BNTX, and BLUE.

Is DNA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7144 seconds.